Tag: plasma therapy market report

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

#Plasma Therapy Market Size And Revenue Outlook Through 2030#_x000D_

The plasma therapy market has experienced rapid expansion in recent years. Its size is expected to increase from $0.61 billion in 2025 to $0.69 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.6%. The historical period’s growth can be linked to factors such as limited understanding of plasma therapy’s advantages, a reliance on traditional treatments, an uptick in orthopedic and sports medicine procedures, the development of hospital and clinic infrastructure, and the early incorporation of PRP in cosmetic applications._x000D_

_x000D_

The plasma therapy market is projected to experience substantial expansion in the coming years. It is set to reach $1.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This anticipated growth during the forecast period is fueled by several factors, including the creation of sophisticated PRP and PRF formulations, an increase in regenerative medicine research, the broader application of plasma therapy in treating chronic and cardiac injuries, its growing use in dermatology and dental care, and the proliferation of clinical trials and research institutions. Key trends for the forecast duration encompass the increasing acceptance of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) treatments, the broadening scope of regenerative medicine and orthopedic applications, greater utilization in dermatology, hair restoration, and plastic surgery, a surge in demand for injectable and membrane-based fibrin items, and the incorporation of research and clinical trials to achieve better therapeutic results._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=57980626&type=smp&name=Plasma%20Therapy%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Plasma Therapy Market Growth Drivers: What’s Behind The Acceleration?#_x000D_

The increasing incidence of osteoarthritis is projected to stimulate growth in the plasma therapy market during the forecast period. Platelet-rich plasma (PRP), a specific kind of plasma therapy, is acknowledged as a safe and effective therapeutic option for osteoarthritis. As a concentrated autologous blood growth factor, Platelet-rich plasma (PRP) is injected into the joint, offering symptomatic relief by diminishing inflammation and decelerating the progression of osteoarthritis. For instance, data from September 2023, published by the Journal of Elsevier, a Netherlands-based publishing company, forecasts that by 2050, the global rise in osteoarthritis cases is anticipated to be 74.9% (ranging from 59.4% to 89.9%) for the knee, 48.6% (ranging from 35.9% to 67.1%) for the hand, 78.6% (ranging from 57.7% to 105.3%) for the hip, and 95.1% (ranging from 68.1% to 135.0%) for other types of osteoarthritis. Common treatments currently utilized for osteoarthritis include autologous chondrocyte implantation and scaffold implants. Therefore, the expanding prevalence of osteoarthritis is expected to be a key driver for the plasma therapy market._x000D_

_x000D_

#Plasma Therapy Market Segment Analysis: What Are The Core Market Categories?#_x000D_

The plasma therapy market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF) _x000D_

2) By Application: Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications _x000D_

3) By End-Users: Hospitals & Clinics, Laboratories: Research Institutes_x000D_

_x000D_

Subsegments:_x000D_

1) By Pure PRP: High Concentration PRP, Low Concentration PRP_x000D_

2) By Leukocyte-Rich PRP: PRP With White Blood Cells, PRP With Growth Factors_x000D_

3) By Pure Platelet-rich Fibrin (PRF): Injectable PRF, Membrane PRF_x000D_

4) By Leukocyte-rich Fibrin (L-PRF): L-PRF Clots, L-PRF Membranes_x000D_

_x000D_

#Plasma Therapy Market Trends: What’s Defining The Industry’s Next Phase?#_x000D_

Key players in the plasma therapy market are bringing innovative products, such as the ESG-410, to meet evolving demands and enhance treatment alternatives. The ESG-410 is an Electrosurgical Generator specifically developed to deliver versatile options and improved efficiency in managing NMIBC (non-muscle-invasive bladder cancer) and benign prostatic hyperplasia. For illustration, in June 2023, Olympus Corporation, a medical technology company based in Japan, introduced its next-generation electrosurgical generator, the ESG-410. This device is utilized for treating bladder cancer and an enlarged prostate. The ESG-410 incorporates advanced design features, including enhanced capacitors, to ensure superior plasma stability during ignition. It offers rapid ignition and optimized plasma stability, marking an improvement over the ESG-400, particularly when employed with different loop sizes and oval buttons. The ESG-410 Electrosurgical Generator provides advanced treatment solutions for NMIBC and BPH by supplying a variety of resection loops, electrodes, and vaporization tools._x000D_

_x000D_

#Plasma Therapy Market Top Companies Driving Competitive Growth#_x000D_

Major companies operating in the plasma therapy market are Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc. _x000D_

_x000D_

#View The Full Plasma Therapy Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/Plasmas-Therapy-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Plasma Therapy Market Top Region By Revenue And Market Share#_x000D_

North America was the largest region in the plasma therapy market in 2025. The Middle East is expected to be the fastest-growing region in the global plasma therapy market share during the forecast period. The regions covered in the plasma therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Plasma Therapy Market Size Outlook: How Fast Will Revenue Grow Through 2030?

The plasma therapy market has experienced rapid expansion in recent years, with its size projected to increase from $0.61 billion in 2025 to $0.69 billion in 2026, representing a compound annual growth rate (CAGR) of 12.6%. The growth observed during the historical period is largely driven by factors such as limited awareness of the benefits associated with plasma therapy, a continued dependence on conventional treatment methods, an increase in orthopedic and sports medicine procedures, the enhancement of hospital and clinic infrastructure, and early adoption of platelet-rich plasma (PRP) in cosmetic applications.

Market projections for the plasma therapy sector indicate swift expansion in the coming years, with a forecasted rise to $1.13 billion by 2030, reflecting a compound annual growth rate (CAGR) of 13.0%. This upward trend during the projection period is driven by advancements in the creation of sophisticated PRP and PRF formulas, heightened activity in regenerative medicine research, a broader range of plasma therapy applications for chronic conditions and cardiac injuries, increased usage in dermatology and dental care, and a surge in clinical trials and research institutions. Key trends shaping this outlook encompass the widespread uptake of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) therapies, the growing scope of regenerative medicine and orthopedic uses, heightened application in dermatology, hair restoration, and plastic surgery, stronger demand for injectable and membrane-based fibrin products, as well as the integration of research initiatives and clinical trials aimed at improving therapeutic results.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3278&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Plasma Therapy Market Development Factors: Which Trends Are Supporting Demand?

The increasing prevalence of osteoarthritis is anticipated to fuel growth in the plasma therapy market throughout the forecast period. Platelet-rich plasma (PRP), a form of plasma therapy, is regarded as a secure and effective option for managing osteoarthritis. PRP consists of concentrated autologous growth factors derived from blood, which are injected into the joint to alleviate symptoms by reducing inflammation and decelerating disease progression. For example, a September 2023 report from the Netherlands-based publishing company Elsevier, published in the Journal of Elsevier, projects that by 2050, global osteoarthritis cases will rise by 74.9% (range: 59.4% to 89.9%) for the knee, 48.6% (range: 35.9% to 67.1%) for the hand, 78.6% (range: 57.7% to 105.3%) for the hip, and 95.1% (range: 68.1% to 135.0%) for other types. Common treatments for osteoarthritis include autologous chondrocyte implantation and scaffold implants. Consequently, a higher incidence of osteoarthritis is expected to boost demand for plasma therapy.

Plasma Therapy Market Segments: Where Are The Largest Growth Opportunities?

The plasma therapy market covered in this report is segmented –

1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)

2) By Application: Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications

3) By End-Users: Hospitals & Clinics, Laboratories: Research Institutes

Subsegments:

1) By Pure PRP: High Concentration PRP, Low Concentration PRP

2) By Leukocyte-Rich PRP: PRP With White Blood Cells, PRP With Growth Factors

3) By Pure Platelet-rich Fibrin (PRF): Injectable PRF, Membrane PRF

4) By Leukocyte-rich Fibrin (L-PRF): L-PRF Clots, L-PRF Membranes

Plasma Therapy Market Transformation Trends: Which Innovations Are Driving Change?

Leading companies in the plasma therapy sector are responding to growing demand by rolling out advanced products like the ESG-410 to broaden treatment possibilities. This Electrosurgical Generator is specifically engineered to deliver greater flexibility and efficiency when managing non-muscle-invasive bladder cancer (NMIBC) and benign prostatic hyperplasia (BPH). A notable example occurred in June 2023, when Olympus Corporation, a Japanese medical technology firm, introduced the next-generation ESG-410 device for treating bladder cancer and enlarged prostate. Its design incorporates upgraded capacitors that enhance plasma stability during ignition, ensuring faster activation and more consistent performance compared to the previous ESG-400 model—especially when used with various loop sizes and oval electrodes. By supplying a diverse selection of resection loops, electrodes, and vaporization tools, the ESG-410 offers improved therapeutic options for both NMIBC and BPH.

Plasma Therapy Market Major Participants And Competitive Dynamics

Major companies operating in the plasma therapy market are Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc.

Access The Complete Plasma Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Plasma Therapy Market Global Footprint: Which Region Holds Market Leadership?

North America was the largest region in the plasma therapy market in 2025. The Middle East is expected to be the fastest-growing region in the global plasma therapy market share during the forecast period. The regions covered in the plasma therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Are The Forecasted Market Size Figures For The Plasma Therapy Market In 2026 And 2030?

The plasma therapy market has experienced substantial expansion recently. Projections indicate it will expand from $0.61 billion in 2025 to $0.69 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 12.6%. The historical growth was influenced by factors such as limited public understanding of plasma therapy benefits, a prevailing dependence on conventional treatments, the rise in orthopedic and sports medicine procedures, expanding hospital and clinic infrastructure, and the initial integration of PRP in cosmetic applications.

The plasma therapy market is anticipated to experience significant expansion in the coming years, with its size projected to reach $1.13 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.0%. This growth during the forecast period is attributed to several factors, including the development of advanced PRP and PRF formulations, an increase in regenerative medicine research, the broadening of plasma therapy applications in chronic and cardiac injuries, rising adoption in dermatology and dental care, and the expansion of clinical trials and research institutes. Key trends anticipated in the forecast period involve the growing acceptance of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) therapies, the expansion of regenerative medicine and orthopedic applications, increased utilization in dermatology, hair restoration, and plastic surgery, a rising demand for injectable and membrane-based fibrin products, and the integration of research with clinical trials to achieve enhanced therapeutic outcomes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3278&type=smp

Which Significant Factors Are Encouraging Growth In The Plasma Therapy Market?

An anticipated increase in osteoarthritis incidents is projected to propel the plasma therapy market throughout the forecast period. Platelet-rich plasma (PRP), a form of plasma therapy, is recognized as a secure and effective therapeutic option for osteoarthritis. PRP, an autologous blood growth factor in concentrated form, is administered via joint injection to alleviate symptoms by reducing inflammation and impeding the advancement of osteoarthritis. Illustratively, a report from September 2023 by the Journal of Elsevier, a Netherlands-based publishing firm, indicates that by 2050, the global increase in osteoarthritis cases is anticipated to reach 74.9% (ranging from 59.4% to 89.9%) for the knee, 48.6% (ranging from 35.9% to 67.1%) for the hand, 78.6% (ranging from 57.7% to 105.3%) for the hip, and 95.1% (ranging from 68.1% to 135.0%) for other categories of osteoarthritis. Among the widely utilized treatments for osteoarthritis are autologous chondrocyte implantation and scaffold implants. Consequently, an escalating incidence of osteoarthritis is foreseen to stimulate growth in the plasma therapy market.

Which Segment-Based Categories Are Covered In The Plasma Therapy Market?

The plasma therapy market covered in this report is segmented –

1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)

2) By Application: Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications

3) By End-Users: Hospitals & Clinics, Laboratories: Research Institutes

Subsegments:

1) By Pure PRP: High Concentration PRP, Low Concentration PRP

2) By Leukocyte-Rich PRP: PRP With White Blood Cells, PRP With Growth Factors

3) By Pure Platelet-rich Fibrin (PRF): Injectable PRF, Membrane PRF

4) By Leukocyte-rich Fibrin (L-PRF): L-PRF Clots, L-PRF Membranes

Which Trends Are Supporting The Evolution Of The Plasma Therapy Market?

Leading companies operating in the plasma therapy market are introducing innovative products such as the ESG-410 to address evolving needs and enhance treatment possibilities. The ESG-410 is an Electrosurgical Generator designed to provide versatile options and efficiencies in managing NMIBC (non-muscle-invasive bladder cancer) and benign prostatic hyperplasia. For instance, in June 2023, Olympus Corporation, a Japan-based medical technology company, launched this next-generation electrosurgical generator, the ESG-410. It is utilized for treating bladder cancer and enlarged prostate. The ESG-410 incorporates advanced design components, such as enhanced capacitors, which ensure superior plasma stability during ignition. It boasts rapid ignition and optimized plasma stability, delivering improvements over the ESG-400, especially when deployed with various loop sizes and oval buttons. The ESG-410 Electrosurgical Generator provides advanced treatment alternatives for NMIBC and BPH by offering a comprehensive range of resection loops, electrodes, and vaporization tools.

Who Are The Key Market Participants In The Plasma Therapy Market?

Major companies operating in the plasma therapy market are Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc.

Access The Complete Plasma Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Which Region Holds The Largest Share In The Plasma Therapy Market?

North America was the largest region in the plasma therapy market in 2025. The Middle East is expected to be the fastest-growing region in the global plasma therapy market share during the forecast period. The regions covered in the plasma therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Plasma Therapy Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=3278&type=smp

Browse Through More Reports Similar to the Global Plasma Therapy Market 2026, By The Business Research Company

Apheresis Consumables And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/apheresis-consumables-and-equipment-global-market-report

Blood Transfusion Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Hematology Analyzers And Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Plasma Therapy Market In 2026, And How Will Its Value Evolve By 2030?

The plasma therapy market has experienced swift expansion recently. Projections indicate its value will increase from $0.61 billion in 2025 to $0.69 billion by 2026, achieving a compound annual growth rate (CAGR) of 12.6%. Historically, this expansion was driven by several factors, including insufficient understanding of plasma therapy’s advantages, a preference for traditional medical approaches, the rising number of orthopedic and sports medicine interventions, an expansion in hospital and clinic facilities, and the initial integration of PRP in cosmetic applications.

The plasma therapy market is projected to experience swift expansion over the coming years. By 2030, its valuation is anticipated to reach $1.13 billion, exhibiting a compound annual growth rate (CAGR) of 13.0%. This projected growth stems from several factors, including the creation of advanced prp and prf formulations, increasing research in regenerative medicine, broadening applications of plasma therapy for chronic and cardiac injuries, greater acceptance in dermatology and dental care, and an increase in clinical trials and research institutes. Key developments anticipated during this period involve the rising uptake of platelet-rich plasma (prp) and platelet-rich fibrin (prf) treatments, wider use in regenerative medicine and orthopedic contexts, expanded application in dermatology, hair restoration, and plastic surgery, a growing need for injectable and membrane-based fibrin products, and the merging of research with clinical trials to improve therapeutic results.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3278&type=smp

What Factors Are Contributing To The Growth Of The Plasma Therapy Market?

The expanding incidence of osteoarthritis is projected to propel the plasma therapy market throughout the forecast period. Platelet-rich plasma (PRP), a variant of plasma therapy, is recognized as a safe and effective method for treating osteoarthritis. This concentrated autologous blood growth factor is administered directly into the joint to offer symptomatic relief by mitigating inflammation and decelerating the condition’s progression. For example, in September 2023, the Journal of Elsevier, a Netherlands-based publishing company, reported projections for osteoarthritis cases globally by 2050, indicating a rise of 74.9% (ranging from 59.4% to 89.9%) for the knee, 48.6% (ranging from 35.9% to 67.1%) for the hand, 78.6% (ranging from 57.7% to 105.3%) for the hip, and 95.1% (ranging from 68.1% to 135.0%) for other osteoarthritis types. Autologous chondrocyte implantation and scaffold implants are among the other widely utilized treatments for osteoarthritis. Hence, the increasing prevalence of osteoarthritis is set to drive the plasma therapy market.

Which Segment Categories Are Included In The Plasma Therapy Market Segment Analysis?

The plasma therapy market covered in this report is segmented –

1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)

2) By Application: Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications

3) By End-Users: Hospitals & Clinics, Laboratories: Research Institutes

Subsegments:

1) By Pure PRP: High Concentration PRP, Low Concentration PRP

2) By Leukocyte-Rich PRP: PRP With White Blood Cells, PRP With Growth Factors

3) By Pure Platelet-rich Fibrin (PRF): Injectable PRF, Membrane PRF

4) By Leukocyte-rich Fibrin (L-PRF): L-PRF Clots, L-PRF Membranes

What Trends Are Influencing The Plasma Therapy Market?

Leading companies active in the plasma therapy market are launching innovative products like the ESG-410 to address evolving patient needs and improve therapeutic choices. The ESG-410 functions as an Electrosurgical Generator, engineered to provide flexibility and effectiveness in the treatment of NMIBC (non-muscle-invasive bladder cancer) and benign prostatic hyperplasia. As an illustration, in June 2023, Olympus Corporation, a Japan-based medical technology firm, introduced its advanced electrosurgical generator, the ESG-410. This device is utilized for managing bladder cancer and an enlarged prostate. The ESG-410 incorporates sophisticated design features, such as improved capacitors, which ensure exceptional plasma stability during ignition. It boasts quick ignition and optimized plasma stability, marking an upgrade from the ESG-400, especially when deployed with various loop sizes and oval buttons. Furthermore, the ESG-410 Electrosurgical Generator offers enhanced treatment solutions for NMIBC and BPH by supplying a comprehensive selection of resection loops, electrodes, and vaporization instruments.

Who Are The Active Companies Shaping The Plasma Therapy Market?

Major companies operating in the plasma therapy market are Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc.

Get The Full Plasma Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Where Is The Plasma Therapy Market Most Concentrated Geographically?

North America was the largest region in the plasma therapy market in 2025. The Middle East is expected to be the fastest-growing region in the global plasma therapy market share during the forecast period. The regions covered in the plasma therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Plasma Therapy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Browse Through More Reports Similar to the Global Plasma Therapy Market 2026, By The Business Research Company

Apheresis Consumables And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/apheresis-consumables-and-equipment-global-market-report

Blood Transfusion Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Hematology Analyzers And Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Plasma Therapy Market During 2026–2030?

The plasma therapy market has witnessed rapid growth in recent years. Its size is expected to expand from $0.61 billion in 2025 to $0.69 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.6%. This historical development can be attributed to several factors such as limited awareness about plasma therapy benefits, a reliance on conventional treatments, an increase in orthopedic and sports medicine procedures, the expansion of hospital and clinic infrastructure, and the early adoption of PRP in cosmetic procedures.

The plasma therapy market is projected to experience swift expansion in the coming years, with its size reaching $1.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This anticipated growth during the forecast period is fueled by several factors, including the creation of sophisticated PRP and PRF formulations, a surge in regenerative medicine research, broader applications of plasma therapy for chronic and cardiac injuries, increased usage in dermatology and dental fields, and the proliferation of clinical trials and research institutions. Key trends anticipated during this period encompass the increasing embrace of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) treatments, the broadening of regenerative medicine and orthopedic uses, their expanding application in dermatology, hair restoration, and plastic surgery, a heightened demand for fibrin products in injectable and membrane forms, and the integration of research with clinical trials to achieve superior therapeutic results.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3278&type=smp

What Underlying Factors Are Accelerating The Growth Of The Plasma Therapy Market?

The increasing incidence of osteoarthritis is anticipated to propel the growth of the plasma therapy market throughout the forecast period. Platelet-rich plasma (PRP), a form of plasma therapy, is recognized as a secure and effective therapeutic option for osteoarthritis. PRP constitutes a concentrated autologous blood growth factor, administered via injection into the affected joint to alleviate symptoms by reducing inflammation and impeding the advancement of osteoarthritis. As an illustration, data from September 2023, published in the Journal of Elsevier, a Netherlands-based publishing entity, indicates that by 2050, the worldwide increase in osteoarthritis cases is forecast to reach 74.9% (with a range of 59.4% to 89.9%) for the knee, 48.6% (ranging from 35.9% to 67.1%) for the hand, 78.6% (ranging from 57.7% to 105.3%) for the hip, and 95.1% (ranging from 68.1% to 135.0%) for other osteoarthritis types. Other prevalent treatments for osteoarthritis include autologous chondrocyte implantation and scaffold implants. Consequently, the growing prevalence of osteoarthritis is anticipated to stimulate the plasma therapy market.

How Are The Various Segments Of The Plasma Therapy Market Categorized?

The plasma therapy market covered in this report is segmented –

1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)

2) By Application: Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications

3) By End-Users: Hospitals & Clinics, Laboratories: Research Institutes

Subsegments:

1) By Pure PRP: High Concentration PRP, Low Concentration PRP

2) By Leukocyte-Rich PRP: PRP With White Blood Cells, PRP With Growth Factors

3) By Pure Platelet-rich Fibrin (PRF): Injectable PRF, Membrane PRF

4) By Leukocyte-rich Fibrin (L-PRF): L-PRF Clots, L-PRF Membranes

What Trends Are Affecting The Expansion Of The Plasma Therapy Market?

Leading companies within the plasma therapy market are introducing innovative products, such as the ESG-410, to address changing requirements and improve treatment possibilities. The ESG-410 functions as an Electrosurgical Generator, designed to offer versatility and efficiency in the management of non-muscle-invasive bladder cancer (NMIBC) and benign prostatic hyperplasia. For instance, in June 2023, Olympus Corporation, a medical technology company based in Japan, unveiled the ESG-410, its next-generation electrosurgical generator. This device is utilized for treating bladder cancer and an enlarged prostate. The ESG-410 incorporates advanced design elements, including enhanced capacitors, which guarantee superior plasma stability during the ignition process. It is notable for its rapid ignition and optimized plasma stability, presenting improvements over the ESG-400, particularly when utilized with various loop sizes and oval buttons. The ESG-410 Electrosurgical Generator facilitates advanced treatment options for NMIBC and BPH by offering a selection of resection loops, electrodes, and vaporization tools.

Which Major Firms Influence Developments In The Plasma Therapy Market?

Major companies operating in the plasma therapy market are Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc.

Read the full plasma therapy market report here:

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Which Region Is Projected To Dominate The Plasma Therapy Market During The Forecast Period?

North America was the largest region in the plasma therapy market in 2025. The Middle East is expected to be the fastest-growing region in the global plasma therapy market share during the forecast period. The regions covered in the plasma therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Plasma Therapy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3278&type=smp

Browse Through More Reports Similar to the Global Plasma Therapy Market 2026, By The Business Research Company

Apheresis Consumables And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/apheresis-consumables-and-equipment-global-market-report

Blood Transfusion Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Hematology Analyzers And Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Plasma Therapy Market During 2026–2030?

The plasma therapy market has witnessed rapid growth in recent years. Its size is expected to expand from $0.61 billion in 2025 to $0.69 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.6%. This historical development can be attributed to several factors such as limited awareness about plasma therapy benefits, a reliance on conventional treatments, an increase in orthopedic and sports medicine procedures, the expansion of hospital and clinic infrastructure, and the early adoption of PRP in cosmetic procedures.

The plasma therapy market is projected to experience swift expansion in the coming years, with its size reaching $1.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This anticipated growth during the forecast period is fueled by several factors, including the creation of sophisticated PRP and PRF formulations, a surge in regenerative medicine research, broader applications of plasma therapy for chronic and cardiac injuries, increased usage in dermatology and dental fields, and the proliferation of clinical trials and research institutions. Key trends anticipated during this period encompass the increasing embrace of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) treatments, the broadening of regenerative medicine and orthopedic uses, their expanding application in dermatology, hair restoration, and plastic surgery, a heightened demand for fibrin products in injectable and membrane forms, and the integration of research with clinical trials to achieve superior therapeutic results.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3278&type=smp

What Underlying Factors Are Accelerating The Growth Of The Plasma Therapy Market?

The increasing incidence of osteoarthritis is anticipated to propel the growth of the plasma therapy market throughout the forecast period. Platelet-rich plasma (PRP), a form of plasma therapy, is recognized as a secure and effective therapeutic option for osteoarthritis. PRP constitutes a concentrated autologous blood growth factor, administered via injection into the affected joint to alleviate symptoms by reducing inflammation and impeding the advancement of osteoarthritis. As an illustration, data from September 2023, published in the Journal of Elsevier, a Netherlands-based publishing entity, indicates that by 2050, the worldwide increase in osteoarthritis cases is forecast to reach 74.9% (with a range of 59.4% to 89.9%) for the knee, 48.6% (ranging from 35.9% to 67.1%) for the hand, 78.6% (ranging from 57.7% to 105.3%) for the hip, and 95.1% (ranging from 68.1% to 135.0%) for other osteoarthritis types. Other prevalent treatments for osteoarthritis include autologous chondrocyte implantation and scaffold implants. Consequently, the growing prevalence of osteoarthritis is anticipated to stimulate the plasma therapy market.

How Are The Various Segments Of The Plasma Therapy Market Categorized?

The plasma therapy market covered in this report is segmented –

1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)

2) By Application: Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications

3) By End-Users: Hospitals & Clinics, Laboratories: Research Institutes

Subsegments:

1) By Pure PRP: High Concentration PRP, Low Concentration PRP

2) By Leukocyte-Rich PRP: PRP With White Blood Cells, PRP With Growth Factors

3) By Pure Platelet-rich Fibrin (PRF): Injectable PRF, Membrane PRF

4) By Leukocyte-rich Fibrin (L-PRF): L-PRF Clots, L-PRF Membranes

What Trends Are Affecting The Expansion Of The Plasma Therapy Market?

Leading companies within the plasma therapy market are introducing innovative products, such as the ESG-410, to address changing requirements and improve treatment possibilities. The ESG-410 functions as an Electrosurgical Generator, designed to offer versatility and efficiency in the management of non-muscle-invasive bladder cancer (NMIBC) and benign prostatic hyperplasia. For instance, in June 2023, Olympus Corporation, a medical technology company based in Japan, unveiled the ESG-410, its next-generation electrosurgical generator. This device is utilized for treating bladder cancer and an enlarged prostate. The ESG-410 incorporates advanced design elements, including enhanced capacitors, which guarantee superior plasma stability during the ignition process. It is notable for its rapid ignition and optimized plasma stability, presenting improvements over the ESG-400, particularly when utilized with various loop sizes and oval buttons. The ESG-410 Electrosurgical Generator facilitates advanced treatment options for NMIBC and BPH by offering a selection of resection loops, electrodes, and vaporization tools.

Which Major Firms Influence Developments In The Plasma Therapy Market?

Major companies operating in the plasma therapy market are Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc.

Read the full plasma therapy market report here:

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Which Region Is Projected To Dominate The Plasma Therapy Market During The Forecast Period?

North America was the largest region in the plasma therapy market in 2025. The Middle East is expected to be the fastest-growing region in the global plasma therapy market share during the forecast period. The regions covered in the plasma therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Plasma Therapy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3278&type=smp

Browse Through More Reports Similar to the Global Plasma Therapy Market 2026, By The Business Research Company

Apheresis Consumables And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/apheresis-consumables-and-equipment-global-market-report

Blood Transfusion Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Hematology Analyzers And Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Plasma Therapy Market During 2026–2030?

The plasma therapy market has witnessed rapid growth in recent years. Its size is expected to expand from $0.61 billion in 2025 to $0.69 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.6%. This historical development can be attributed to several factors such as limited awareness about plasma therapy benefits, a reliance on conventional treatments, an increase in orthopedic and sports medicine procedures, the expansion of hospital and clinic infrastructure, and the early adoption of PRP in cosmetic procedures.

The plasma therapy market is projected to experience swift expansion in the coming years, with its size reaching $1.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This anticipated growth during the forecast period is fueled by several factors, including the creation of sophisticated PRP and PRF formulations, a surge in regenerative medicine research, broader applications of plasma therapy for chronic and cardiac injuries, increased usage in dermatology and dental fields, and the proliferation of clinical trials and research institutions. Key trends anticipated during this period encompass the increasing embrace of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) treatments, the broadening of regenerative medicine and orthopedic uses, their expanding application in dermatology, hair restoration, and plastic surgery, a heightened demand for fibrin products in injectable and membrane forms, and the integration of research with clinical trials to achieve superior therapeutic results.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3278&type=smp

What Underlying Factors Are Accelerating The Growth Of The Plasma Therapy Market?

The increasing incidence of osteoarthritis is anticipated to propel the growth of the plasma therapy market throughout the forecast period. Platelet-rich plasma (PRP), a form of plasma therapy, is recognized as a secure and effective therapeutic option for osteoarthritis. PRP constitutes a concentrated autologous blood growth factor, administered via injection into the affected joint to alleviate symptoms by reducing inflammation and impeding the advancement of osteoarthritis. As an illustration, data from September 2023, published in the Journal of Elsevier, a Netherlands-based publishing entity, indicates that by 2050, the worldwide increase in osteoarthritis cases is forecast to reach 74.9% (with a range of 59.4% to 89.9%) for the knee, 48.6% (ranging from 35.9% to 67.1%) for the hand, 78.6% (ranging from 57.7% to 105.3%) for the hip, and 95.1% (ranging from 68.1% to 135.0%) for other osteoarthritis types. Other prevalent treatments for osteoarthritis include autologous chondrocyte implantation and scaffold implants. Consequently, the growing prevalence of osteoarthritis is anticipated to stimulate the plasma therapy market.

How Are The Various Segments Of The Plasma Therapy Market Categorized?

The plasma therapy market covered in this report is segmented –

1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)

2) By Application: Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications

3) By End-Users: Hospitals & Clinics, Laboratories: Research Institutes

Subsegments:

1) By Pure PRP: High Concentration PRP, Low Concentration PRP

2) By Leukocyte-Rich PRP: PRP With White Blood Cells, PRP With Growth Factors

3) By Pure Platelet-rich Fibrin (PRF): Injectable PRF, Membrane PRF

4) By Leukocyte-rich Fibrin (L-PRF): L-PRF Clots, L-PRF Membranes

What Trends Are Affecting The Expansion Of The Plasma Therapy Market?

Leading companies within the plasma therapy market are introducing innovative products, such as the ESG-410, to address changing requirements and improve treatment possibilities. The ESG-410 functions as an Electrosurgical Generator, designed to offer versatility and efficiency in the management of non-muscle-invasive bladder cancer (NMIBC) and benign prostatic hyperplasia. For instance, in June 2023, Olympus Corporation, a medical technology company based in Japan, unveiled the ESG-410, its next-generation electrosurgical generator. This device is utilized for treating bladder cancer and an enlarged prostate. The ESG-410 incorporates advanced design elements, including enhanced capacitors, which guarantee superior plasma stability during the ignition process. It is notable for its rapid ignition and optimized plasma stability, presenting improvements over the ESG-400, particularly when utilized with various loop sizes and oval buttons. The ESG-410 Electrosurgical Generator facilitates advanced treatment options for NMIBC and BPH by offering a selection of resection loops, electrodes, and vaporization tools.

Which Major Firms Influence Developments In The Plasma Therapy Market?

Major companies operating in the plasma therapy market are Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc.

Read the full plasma therapy market report here:

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Which Region Is Projected To Dominate The Plasma Therapy Market During The Forecast Period?

North America was the largest region in the plasma therapy market in 2025. The Middle East is expected to be the fastest-growing region in the global plasma therapy market share during the forecast period. The regions covered in the plasma therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Plasma Therapy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3278&type=smp

Browse Through More Reports Similar to the Global Plasma Therapy Market 2026, By The Business Research Company

Apheresis Consumables And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/apheresis-consumables-and-equipment-global-market-report

Blood Transfusion Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Hematology Analyzers And Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the plasma therapy market from 2026–2035 with trusted insights from The Business Research Company

How much is the Plasma Therapy Market valued at in 2026, and what valuation is forecast for 2030?

The plasma therapy market has demonstrated significant expansion in its size during recent years. It is projected to increase from $0.61 billion in 2025 to $0.69 billion in 2026, at a compound annual growth rate (CAGR) of 12.6%. This growth experienced in the past can be attributed to factors such as limited public understanding of plasma therapy benefits, continued reliance on traditional medical interventions, an increasing number of orthopedic and sports medicine procedures, the expansion of hospital and clinic infrastructure, and the early integration of PRP in cosmetic applications.

The plasma therapy market is projected to experience substantial expansion in the coming years. By 2030, its valuation is anticipated to reach $1.13 billion, demonstrating a compound annual growth rate (CAGR) of 13.0%. This growth over the forecast period is fueled by several factors, including the advancement of innovative PRP and PRF formulations, a surge in regenerative medicine research, the broadening scope of plasma therapy applications for chronic and cardiac injuries, greater acceptance in dermatology and dental care settings, and the proliferation of clinical trials and research institutions. Key trends anticipated during this period encompass the increasing integration of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) treatments, the wider application in regenerative medicine and orthopedics, a growing presence in dermatology, hair restoration, and plastic surgery procedures, an escalating need for injectable and membrane-based fibrin products, and the merging of research with clinical trials to achieve superior therapeutic results.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3278&type=smp

What Drivers Are Influencing The Growth Of The Plasma Therapy Market?

The escalating incidence of osteoarthritis is projected to propel the plasma therapy market throughout the forecast period. Platelet-rich plasma (PRP), identified as a safe and effective plasma therapy, serves as a concentrated autologous blood growth factor that is injected directly into the joint to offer symptomatic relief by reducing inflammation and slowing the progression of osteoarthritis. For instance, a report from September 2023 by the Journal of Elsevier, a Netherlands-based publishing company, indicates a projected global rise in osteoarthritis cases by 2050. Specifically, this increase is expected to be 74.9% (ranging from 59.4% to 89.9%) for the knee, 48.6% (ranging from 35.9% to 67.1%) for the hand, 78.6% (ranging from 57.7% to 105.3%) for the hip, and 95.1% (ranging from 68.1% to 135.0%) for other osteoarthritis types. Although autologous chondrocyte implantation and scaffold implants are among other widely used treatments for osteoarthritis, the overall surge in osteoarthritis prevalence is expected to significantly drive the plasma therapy market.

How Is The Plasma Therapy Market Organized Into Various Segments?

The plasma therapy market covered in this report is segmented –

1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)

2) By Application: Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications

3) By End-Users: Hospitals & Clinics, Laboratories: Research Institutes

Subsegments:

1) By Pure PRP: High Concentration PRP, Low Concentration PRP

2) By Leukocyte-Rich PRP: PRP With White Blood Cells, PRP With Growth Factors

3) By Pure Platelet-rich Fibrin (PRF): Injectable PRF, Membrane PRF

4) By Leukocyte-rich Fibrin (L-PRF): L-PRF Clots, L-PRF Membranes

Which Trends Are Shaping Activity Within The Plasma Therapy Market?

Major companies within the plasma therapy market are introducing innovative products like the ESG-410 to address evolving needs and enhance treatment options. The ESG-410 functions as an Electrosurgical Generator, specifically designed to provide versatility and improved efficiency in treating NMIBC (non-muscle-invasive bladder cancer) and benign prostatic hyperplasia. For example, in June 2023, Olympus Corporation, a medical technology company based in Japan, launched this next-generation electrosurgical generator, the ESG-410. It is utilized for managing bladder cancer and an enlarged prostate. The ESG-410 incorporates advanced design elements, such as enhanced capacitors, ensuring superior plasma stability during ignition. It offers rapid ignition and optimized plasma stability, showcasing improvements over the ESG-400, particularly when used with various loop sizes and oval buttons. The ESG-410 Electrosurgical Generator provides advanced treatment avenues for NMIBC and BPH by offering a range of resection loops, electrodes, and vaporization tools.

Who Are The Prominent Global Companies Shaping The Plasma Therapy Market Landscape?

Major companies operating in the plasma therapy market are Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Plasma Therapy Market?

North America was the largest region in the plasma therapy market in 2025. The Middle East is expected to be the fastest-growing region in the global plasma therapy market share during the forecast period. The regions covered in the plasma therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Plasma Therapy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3278&type=smp

Browse Through More Reports Similar to the Global Plasma Therapy Market 2026, By The Business Research Company

Apheresis Consumables And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/apheresis-consumables-and-equipment-global-market-report

Blood Transfusion Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Hematology Analyzers And Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model